Ji Yao Holding(300108)
Search documents
ST吉药(300108) - 2014 Q1 - 季度财报
2014-04-16 16:00
Financial Performance - Total revenue for Q1 2014 was CNY 40,934,455.24, representing a 36.6% increase compared to CNY 29,966,164.09 in the same period last year[9] - Net profit attributable to ordinary shareholders was CNY 6,025,053.87, up 7.26% from CNY 5,617,032.72 year-on-year[9] - Basic earnings per share increased by 12.5% to CNY 0.045 from CNY 0.04 in the same period last year[9] - Operating profit increased by 69.99% to 7,738,874.88 yuan, attributed to higher product sales and increased average selling prices[17] - The total profit for Q1 2014 was CNY 7,165,659.19, which is an increase of 6.8% from CNY 6,708,914.81 in Q1 2013[42] - The company's net profit margin improved, with net profit increasing to CNY 7,738,874.88 from CNY 4,552,473.56, representing a growth of about 69.0%[40] Cash Flow - The net cash flow from operating activities was negative CNY 25,603,240.08, a decline of 18.01% compared to negative CNY 21,696,627.54 in the previous year[9] - Cash inflow from operating activities was 40,606,930.20 yuan, a growth of 38.48% year-on-year, reflecting increased sales revenue[18] - Cash outflow from operating activities rose to 54,989,652.28 yuan, up 33.07% year-on-year, primarily due to increased material purchases[18] - The cash flow from operating activities showed a net outflow of CNY -25,603,240.08, compared to CNY -21,696,627.54 in the same period last year[47] - The net cash flow from operating activities was -26,996,906.67 CNY, compared to -23,608,906.22 CNY in the previous year, indicating a decline of approximately 10.1%[51] - The net increase in cash and cash equivalents was -28,141,536.83 CNY, compared to -4,314,882.22 CNY in the same period last year, reflecting a significant decline[52] Assets and Liabilities - Total assets at the end of the reporting period were CNY 473,054,405.37, a 1.55% increase from CNY 465,831,664.21 at the end of the previous year[9] - Current assets rose to CNY 180,599,734.69, up from CNY 167,514,289.03, indicating an increase of about 7.5%[34] - Total liabilities increased to CNY 69,029,061.13 from CNY 67,833,656.14, reflecting a growth of approximately 1.8%[36] - Shareholders' equity rose to CNY 404,025,344.24 from CNY 397,998,008.07, indicating an increase of about 1.5%[36] Sales and Expenses - The company's revenue for the reporting period was 40,934,455.24 yuan, an increase of 36.60% year-on-year, driven by a 28.12% increase in product sales volume and higher sales of premium products[17] - Sales expenses rose to 3,640,858.88 yuan, up 47.02% year-on-year, due to increased sales volume and growth in the southern market[17] - Operating costs rose to CNY 33,195,580.36 from CNY 25,413,690.53, which is an increase of approximately 30.6%[40] - Sales expenses increased to CNY 3,334,526.11 in Q1 2014, up from CNY 2,449,511.25 in the previous year, reflecting a rise of 36.1%[44] - Management expenses also rose to CNY 3,902,969.91, compared to CNY 2,979,554.66 in Q1 2013, marking a 30.9% increase[44] Future Outlook - The company expects continued improvement in performance due to recovering demand in the silica gel market, despite challenges from increased depreciation and labor costs[11] - The company expects continued improvement in sales performance in the next quarter due to recovering demand in the silicone rubber market[19] - The company plans to enhance product industrialization and expand sales channels to ensure stable growth in performance[11] - The company plans to enhance cost efficiency through technological and management innovations, aiming for stable growth in performance[19] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,605[12] - The cash dividend policy was approved, with a proposal to distribute 1 RMB per 10 shares based on a total share capital of 13,520 million shares[29] - No cash dividends will be distributed in the first quarter of 2014[30] - There are no plans for share buybacks or significant shareholder actions reported during the period[31] Government Subsidies and Fundraising - The company received government subsidies totaling CNY 429,530.55 during the reporting period[10] - The total amount of raised funds for the quarter is 26,624,000 RMB[26] - The cumulative amount of raised funds used is 23,574.29 million RMB, with a 0% change in purpose[26] - The company has raised 113 million RMB in excess funds, with specific allocations for investments and loan repayments[27]
ST吉药(300108) - 2013 Q4 - 年度财报
2014-01-20 16:00
Financial Performance - The company reported a total revenue of 1.2 billion CNY for the year 2013, representing a year-on-year increase of 15%[20]. - The net profit attributable to shareholders was 150 million CNY, an increase of 10% compared to the previous year[20]. - The gross profit margin improved to 35%, up from 32% in 2012, indicating better cost management and pricing strategies[20]. - The company achieved operating revenue of CNY 164.81 million in 2013, a 3.07% increase compared to CNY 159.90 million in 2012[21]. - Operating profit decreased by 17.03% to CNY 26.81 million in 2013 from CNY 32.31 million in 2012[21]. - Net profit attributable to shareholders was CNY 27.16 million, down 9.77% from CNY 30.10 million in the previous year[21]. - The company reported a net cash flow from operating activities of CNY 18.13 million, an increase of 45.31% compared to CNY 12.48 million in 2012[21]. - The company’s main business revenue for 2013 was ¥164,814,146.84, an increase of 3.07% compared to the previous year[34]. - Operating profit decreased by 17.03% to ¥26,811,022.16, while total profit fell by 8.72% to ¥32,231,293.24[34]. - Net profit attributable to the parent company was ¥27,161,227.04, down 9.77% year-on-year[34]. - The total operating revenue for the year was CNY 164,814,146.84, an increase of 3.7% compared to CNY 159,898,590.46 in the previous year[146]. - The net profit for the year was CNY 27,161,227.04, a decrease of 9.7% from CNY 30,101,822.92 in the previous year[147]. - The earnings per share (EPS) decreased to CNY 0.20 from CNY 0.22, representing a decline of 9.1%[147]. Market Expansion and Strategy - User data showed a 20% increase in the number of clients served, reaching 1,500 clients by the end of 2013[20]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in sales from this region in 2014[20]. - A strategic acquisition of a local competitor is under consideration, which could enhance market share by 15%[20]. - The company aims for a revenue growth target of 20% for 2014, driven by new product launches and market expansion efforts[20]. - The company plans to enhance product competitiveness through technological and management innovations, aiming to reduce costs and improve material utilization[36]. - The company is focusing on entering the green tire market, driven by increasing global demand and environmental awareness[68]. - Future outlook indicates a commitment to market expansion and potential mergers and acquisitions to strengthen its competitive position[113]. Research and Development - The company has allocated 100 million CNY for research and development in 2014, focusing on innovative chemical solutions[20]. - Research and development expenses amounted to ¥5,356,866.10, representing 4.16% of the company's operating revenue[39]. - The company is currently developing several new products, including white carbon black for green tires and food additives, with some in the customer trial phase[41]. - The company has been focusing on expanding its product lines and enhancing its technological capabilities, particularly in the field of silicon dioxide products[112]. - The company has a strong emphasis on research and development, particularly in new materials and chemical products[112]. Financial Health and Management - Total assets increased by 16.06% to CNY 465.83 million at the end of 2013 from CNY 401.38 million at the end of 2012[21]. - Total liabilities surged by 298.48% to CNY 67.83 million in 2013 from CNY 17.02 million in 2012[21]. - The company’s total current assets reached RMB 167,514,289.03, up from RMB 110,696,218.85, indicating a significant increase of about 51%[138]. - The cash and cash equivalents increased to RMB 31,572,136.82 from RMB 13,917,279.14, representing a growth of approximately 127%[138]. - The company maintained a standard unqualified audit opinion for its financial statements for the year 2013, indicating compliance with accounting standards[135]. - The company’s total liabilities increased to RMB 67,833,656.14 from RMB 17,023,183.21, which is an increase of approximately 298%[140]. - The total equity attributable to shareholders reached RMB 397,998,008.07, up from RMB 384,356,781.03, reflecting a growth of about 3.0%[140]. Shareholder and Dividend Information - The board has approved a dividend payout of 0.5 CNY per share, reflecting a commitment to returning value to shareholders[20]. - The cash dividend for 2013 represented 49.78% of the net profit attributable to shareholders, consistent with the company's cash dividend policy[76]. - The company has maintained a cash dividend payout ratio of 100% for the 2013 fiscal year, indicating a strong commitment to returning profits to shareholders[69]. - The total distributable profit at the end of 2013 was ¥107,654,660.95, which included retained earnings from previous years[71]. - The company distributed dividends and interest payments totaling 15,451,666.65 RMB during the year, compared to 6,760,000.00 RMB in the previous year[160]. Operational Efficiency and Risk Management - The company plans to implement benchmarking management and optimize cost control to enhance economic efficiency in 2014[33]. - The company aims to improve product quality and management processes to achieve steady growth in performance[33]. - The company faces risks related to market competition, operational management, financial management, and talent management due to rapid expansion[29][30]. - The company is actively pursuing new strategies to enhance operational efficiency and drive growth in the coming years[113]. Corporate Governance and Compliance - The company has a governance structure that complies with relevant laws and regulations, with no discrepancies reported[123]. - The company held its annual general meeting on May 2, 2013, and the resolutions were published on May 3, 2013[124]. - The company has established a system for accountability regarding significant errors in annual reports, with no major accounting errors reported during the period[128]. - The company has maintained compliance with all commitments made by major shareholders, with no violations reported[90]. - The current auditor, Zhongzhun Accounting Firm, has been engaged for one year, with an audit fee of 300,000 yuan[94]. Employee and Management Information - The total number of employees is 311, with 75.24% being production personnel[119]. - R&D personnel account for 11.25% of the total workforce[119]. - The current management team includes 7 directors and 3 supervisors, with key positions held by experienced professionals in the industry[108][111]. - The total remuneration paid to directors, supervisors, and senior management in 2013 amounted to CNY 15,778,200[116]. - The total remuneration for the chairman and general manager, Lu Zhongkui, was CNY 20,000[117].